SAPS warns public on dagga use and trade

The SAPS is mandated and will act not only against businesses that sell cannabis illegally but also against the customers who buy these products.

November 6, 2019

Zaid Khumalo 3 minutes read

The police have warned members of the public that dealing in dagga is still illegal and that users could be arrested for being in possession of and even transporting the substance.

The South African Police Service has issued a stern warning to the public and online sites and social media platforms that offer dispensaries/outlets marketing and selling cannabis and cannabis-related products that except they’re operating within the legal framework of Medicine and Related Substance Act that they are breaking the law and are liable to prosecution.

According to a statement issued by the SAPS yesterday, some of these illegal businesses, purporting to be operating legally in terms of the Traditional Health Practitioners Act (No. 22 of 2007), are also being sold to members of the public as franchises authorised to deal in cannabis and cannabis-related products.

ALSO READ:

Alleged dagga dealer with pending case against him arrested in Primrose

In terms of the Traditional Health Practitioners Act, the definition of “traditional medicine” means an object or substance used in traditional health practice for the diagnosis, treatment or prevention of a physical or mental illness or any curative or therapeutic purpose, including the maintenance or restoration of physical or mental health or well-being in human beings, but does not include a dependence-producing or dangerous substance or drug”.

As a result, the Traditional Health Practitioners Act does not create a mechanism to sell cannabis and cannabis-related products that are not exempted in terms of the Medicines Act.

‘The public is once again reminded of the effect of the Constitutional Court judgment in Minister of Justice and Constitutional Development and Others v Prince: National Director of Public Prosecutions and Others v Rubin: National Director of Public Prosecutions and Others v Acton and Others [2018] SACC 30, handed down on September 18, 2018. The effect of the judgment is that only an adult person (18 years and older) may use, possess or cultivate cannabis in private for his or her personal consumption in private.

The use, including smoking, of cannabis in public or in the presence of children or in the presence of non-consenting adults is not allowed. The use or possession of cannabis in private other than by an adult for his or her personal consumption is also not permitted.

Dealing in cannabis remains a serious criminal offence in terms of the Drugs and Drug Trafficking Act (No 140 of 1992).

The definition of dealing is made very clear in the Drugs and Drug Trafficking Act, which currently reads (with the words “read in” by the Constitutional Court) “in relation to a drug, includes performing any act in connection with the trans-shipment, importation, cultivation other than the cultivation of cannabis by an adult in a private place for his or her personal consumption in private, collection, manufacture, supply, prescription, administration, sale, transmission or exportation of the drug”.

ALSO READ:

Separating the facts from fiction about using dagga

Cannabis (the whole plant or parts or products thereof) and tetrahydrocannabinol (THC), the psychoactive substance that gives one a “high”, are currently listed as schedule seven substances in terms of the Medicines and Related Substances Act, 1965 (Act 101 of 1965) (the Medicines Act), except when present in processed hemp fibre and products containing not more than 0.1 per cent of THC in a form not suitable for ingestion, smoking or inhaling purposes; or when present in processed products made from cannabis seed containing not more than 0.001 per cent of THC; or when used for medicinal purposes.

Cannabidiol (CBD) is listed as a schedule four substance. Certain CBD-containing preparations have been excluded from the operation of the schedules by the Minister of Health for a time-limited period, as per an exclusion notice (R.756) published in Government Gazette No. 42477 on 23 May 2019. CBD-containing preparations for medicinal use are excluded when they contain a maximum daily dose of 20 mg of CBD with an accepted low-risk claim or health claims, without referring to any specific disease.

CBD-containing processed products are also excluded when the naturally occurring quantity of CBD and THC contained in the product does not exceed 0.0075 per cent and 0.001 per cent of CBD and THC respectively. Any CBD-containing products that are outside the parametres of the exclusion notice are subject to the provisions of the schedules and registration as a medicine.

Any person who imports or manufactures a CBD-containing medicine in accordance with the exclusion notice must still be in possession of a licence issued in terms of section 22C(1)(b) of the Medicines Act and comply with any relevant standards, including current Good Manufacturing Practice (cGMP) standards. Such persons must be able to present verified assessment by an accredited laboratory of the CBD and/or THC content of any product or medicine when requested.

ALSO READ:

Things to keep in mind now that growing dagga at home has been decriminalised

Members of the public are encouraged to download the MySAPSApp on any iPhone or Android to have easy access to the police to, among others, provide tip-offs or one may to report any information relating to the sale of cannabis to the SAPS through the SAPS Crime Stop number (086 00 10111). Callers may remain anonymous and all information will be treated in the strictest confidence.

https://www.saps.gov.za/newsroom/msspeechdetail.php